AstraZeneca Sues Pharmacy Over "Bait And Switch" Tactic With Popular Asthma Drug
AstraZeneca has sued a manufacturer for trademark infringement and false advertising under the Lanham Act, alleging a copycat version of its inhaled asthma medication Pulmicort Respules is forced on unsuspecting customers....To view the full article, register now.
Already a subscriber? Click here to view full article